Evidence map›Paper›PMID 9049787›Full record

ArticleJournal of clinical immunology1997

Programmed cell death (apoptosis) in cord blood lymphocytes.

S Aggarwal, A Gupta, S Nagata, S Gupta

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Umbilical cord blood immunology: relevance to stem cell transplantation.Clinical reviews in allergy & immunology · 2012
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

S AggarwalBasic and Clinical Immunology, University of California, Irvine 92697, USA.
A Gupta
S Nagata
S Gupta
University of California, Irvine · USOsaka Science Museum · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cord blood lymphocytes are functionally immature and have deficient immune responses. In order to determine whether the process of programmed cell death is distinct between cord blood and peripheral blood lymphocytes, we analyzed the expression of fas and bax (apoptosis promoting genes) and bcl-2 and bcl-xL (apoptosis inhibiting genes) at protein or mRNA levels using flow cytometry and quantitative PCR methods, respectively. The susceptibility of T cell subsets from cord blood and adult peripheral blood to undergo apoptosis following restimulation with anti-CD3 or anti-Fas monoclonal antibodies was also studied. We observed that cord blood T cell subsets expressed lower levels of Fas and Bcl-2, a low bcl-2/bax ratio, and higher bcl-xL compared to peripheral blood. Additionally, upon primary stimulation with anti-CD3, cord blood T cell subsets were more resistant to apoptosis compared to peripheral blood. In contrast, rechallenge of previously stimulated lymphocytes with anti-CD3 monoclonal antibody triggered apoptosis in a larger proportion of T cells from cord blood as compared to peripheral blood, whereas the number of T cells undergoing anti-Fas-induced programmed cell death were lower in cord blood compared to peripheral blood.

Indexed as

AdultApoptosisbcl-2-Associated X ProteinFas Ligand Proteinfas ReceptorFetal BloodHumansLigandsMembrane GlycoproteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2RNA, MessengerT-Lymphocyte SubsetsBAX protein, humanbcl-2-Associated X ProteinFASLG protein, humanFas Ligand Proteinfas ReceptorLigandsMembrane GlycoproteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-bcl-2RNA, Messenger

Identifiers

PMID9049787
OpenAlexW161520870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.